MiMedx Group, Inc. (NASDAQ:MDXG) Position Increased by Fmr LLC

Fmr LLC lifted its holdings in MiMedx Group, Inc. (NASDAQ:MDXG) by 29.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 53,869 shares of the company’s stock after purchasing an additional 12,371 shares during the period. Fmr LLC’s holdings in MiMedx Group were worth $318,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of MDXG. Bank of New York Mellon Corp lifted its holdings in shares of MiMedx Group by 9.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 409,344 shares of the company’s stock worth $2,837,000 after purchasing an additional 35,107 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in MiMedx Group by 9.2% in the second quarter. Allspring Global Investments Holdings LLC now owns 181,199 shares of the company’s stock valued at $1,256,000 after buying an additional 15,240 shares during the last quarter. Cannon Global Investment Management LLC bought a new stake in MiMedx Group in the second quarter valued at $118,000. Victory Capital Management Inc. boosted its holdings in shares of MiMedx Group by 909.0% during the second quarter. Victory Capital Management Inc. now owns 138,449 shares of the company’s stock valued at $959,000 after acquiring an additional 124,727 shares during the period. Finally, Los Angeles Capital Management LLC bought a new position in shares of MiMedx Group during the second quarter worth about $988,000. 79.15% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, MiMedx Group has a consensus rating of “Buy” and a consensus price target of $12.00.

MiMedx Group Trading Up 0.2 %

Shares of MDXG stock opened at $9.10 on Friday. MiMedx Group, Inc. has a 1 year low of $5.47 and a 1 year high of $10.14. The firm has a market capitalization of $1.34 billion, a PE ratio of 16.55 and a beta of 1.98. The stock has a fifty day moving average of $8.01 and a two-hundred day moving average of $7.09. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.